ArticleNeuro-oncology2020

Targeting MEK/MELK in atypical teratoid rhabdoid tumor: a treatment approach aimed at exploiting blood-brain barrier deficiencies.

Dean Popovski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.